Jagadishwar Pharmaceutical Works Limited, a active public limited company, was established on 20 November 1987 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the financial and insurance service sector, it holds CIN: L24232AS1987PLC002803. Registered under ROC Roc Kolkata. it is listed. It has an authorized capital of ₹29.75 Cr and a paid-up capital of ₹29.70 Cr.
It upholds a compliant status. In 2023, it reported revenue of ₹4.41 M and a net worth of ₹31.05 Cr. Its leadership includes Soma Ghosh (Director), Tulika Paul (Director), Sandip Kumar Singh (Director). Past directors included Ajay Kulthia, Uma Rani Yalamanchili, Gunodhar Ghosh. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 21/7, Sahapur Colony, Ground Floor, Kolkata, Kolkata, West Bengal, 700053.
L24232WB1987PLC281952
281952
20 November 1987
₹29.75 Cr
₹29.70 Cr
Roc Kolkata
Listed
Active
Explore comprehensive insights into Jagadishwar Pharmaceutical Works Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Soma Ghosh | Director | 03 May 2021 | Current |
| Tulika Paul | Director | 03 May 2021 | Current |
| Sandip Kumar Singh | Director | 01 May 2019 | Current |
| Gunodhar Ghosh | Director | 16 Aug 2019 | Current |
| Swapan Sarkar | Managing Director | 21 May 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 May 2012 | Past |
| Pramod Abcsdd | Director | 22 Nov 2008 | Past |
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jagadishwar Pharmaceutical Works Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.86% decrease. The company also saw a substantial fall in profitability, with a 32.52% decrease in profit. The company's net worth moved up by a moderate rise of 0.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Jagadishwar Pharmaceutical Works had a promoter holding of 10.65% and a public holding of 89.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Jagadishwar Pharmaceutical Works, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Jagadishwar Pharmaceutical Works, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagadishwar Pharmaceutical Works's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Swapan Sarkar was appointed as a Cfo was appointed as a Cfo on 23 Sep 2025 & has been associated with this company since 2 months 11 days . was documented.
The activity Jagadishwar Pharmaceutical Works Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Jagadishwar Pharmaceutical Works Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.
Soma Ghosh was appointed as a Director was appointed as a Director on 03 May 2021 & has been associated with this company since 4 years 7 months . was recorded as a recent event.
The activity Tulika Paul was appointed as a Director was appointed as a Director on 03 May 2021 & has been associated with this company since 4 years 7 months . was completed.
Gunodhar Ghosh was appointed as a Director was appointed as a Director on 16 Aug 2019 & has been associated with this company since 6 years 3 months . was recorded as a recent event.
The CIN of Jagadishwar Pharmaceutical Works Limited is L24232WB1987PLC281952.
Jagadishwar Pharmaceutical Works Limited is headquartered at 21/7, Sahapur Colony, Ground Floor, Kolkata, Kolkata, West Bengal, 700053.
Jagadishwar Pharmaceutical Works Limited was incorporated on 20 November 1987.
The current directors of Jagadishwar Pharmaceutical Works Limited are
The primary industry of Jagadishwar Pharmaceutical Works Limited is Financial And Insurance Service.
Jagadishwar Pharmaceutical Works Limited is listed.
The authorized capital of Jagadishwar Pharmaceutical Works Limited is ₹29.75 Cr, and the paid-up capital is ₹29.70 Cr.
The compliance status of Jagadishwar Pharmaceutical Works Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX